Tracy Zimmermann
Vermogen: - $ op 31-10-2026
Vermogen: - $ op 31-10-2026
Tracy Zimmermann is Chief Scientific Officer at City Therapeutics, Inc. since 2024.
Formerly, Dr. Zimmermann was Chief Development Officer at Generation Bio Co. from 2020 to 2024 and Senior Director-Research at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Education includes undergraduate studies at Lehigh University and a doctorate from the University of Colorado Boulder.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 16-10-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERATION BIO CO. | Corporate Officer/Principal | 28-01-2024 |
| ALNYLAM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau